Onco-cardiology, or Cardio-oncology

I was at a Cardiology Education Meeting where a case was presented of a patient receiving a monoclonal antibody for melanoma, who may have then developed myocarditis.
Onco-cardiology (or cardio-oncology) is the study of the cardiac effects of cancer treatment but also used to refer to patients who are cancer survivors with a cardiac condition or people living with both conditions.

Though not a new term, I don't remember coming across it before.   

Here is some introductory reading:

Some recent freely available articles (with links to PubMed):

Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment. (review)


Cardio-oncology/onco-cardiology (review)

Cardio-oncology: what you need to know now for clinical practice and echocardiography. (review) 


Evaluation and management of patients with heart disease and cancer: cardio-oncology. (review)

Onco-cardiology: the time has come.

An update on cardio-oncology.

There is also a review from JAMA Cardiology (not free).

The American College of Cardiology  and American Society for Clinical Oncology have pages about onco-cardiology.

Then there are Canadian guidelines on the evaluation of cardiovascular complications of cancer therapy.

And a freely available 2013 European Heart Journal article about cancer drugs and the heart.



(All links were checked on 6th February 2018)